There are 2934 resources available
1983 - Prognostic and predictive impact of high tumor mutation burden (TMB) in solid tumors: a systematic review and meta-analysis
Presenter: Mairead McNamara
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
2699 - Comparison of Platforms for Determining Tumor Mutational Burden (TMB) in Patients With Non-Small Cell Lung Cancer (NSCLC)
Presenter: Jonathan Baden
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
2434 - Prevalence and prognostic effect of high tumor mutation burden (TMB-H) across multiple less common solid cancers using a real-world dataset
Presenter: Daniel Backenroth
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
2495 - Docetaxel for hormone-naïve prostate cancer (PCa): results from long-term follow-up of non-metastatic (M0) patients in the STAMPEDE randomised trial (NCT00268476)
Presenter: Nicholas James
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1199 - Benefit of prostate radiotherapy for patients with lymph node only or < 4 bone metastasis and no visceral metastases: Exploratory analyses of metastatic site and number in the STAMPEDE “M1_RT comparison”
Presenter: Syed Adnan Ali
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
1910 - Patient-Reported Outcomes (PROs) From TITAN: a Phase 3, Randomized, Double-Blind Study of Apalutamide (APA) Versus Placebo (PBO) Added to Androgen Deprivation Therapy (ADT) in Patients (pts) With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)
Presenter: Neeraj Agarwal
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract
5435 - TCR-beta repertoire convergence and evenness are associated with response to immune checkpoint inhibitors
Presenter: Philip Jermann
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
5443 - Harmonization study of Tumour Mutational Burden determination in Non-Small-Cell Lung Cancer (NSCLC)
Presenter: Eva M Garrido-Martin
Session: Poster Discussion 1 – Translational research
Resources:
Abstract
Presentation by expert
Presenter: Maria De Santis
Session: Specificity of upper tract urothelial carcinoma biology and management
Resources:
Slides
3405 - Pre-specified interim analysis of GALAHAD: A phase 2 study of niraparib in patients (pts) with metastatic castration-resistant prostate cancer (mCRPC) and biallelic DNA-repair gene defects (DRD)
Presenter: Matthew Smith
Session: Poster Discussion – Genitourinary tumours, prostate
Resources:
Abstract